Glutamine supplementation and GH/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance.
Umpleby
A M
AM
Department of Diabetes, Endocrinology, and Internal Medicine, GKT School of Medicine, St. Thomas' Hospital, London, United Kingdom.
Carroll
P V
PV
Russell-Jones
D L
DL
Treacher
D F
DF
Jackson
N C
NC
D000368:Aged; D016638:Critical Illness / Q000628:therapy*; D019587:Dietary Supplements; D004357:Drug Synergism; D005260:Female; D005973:Glutamine / Q000008:administration & dosage* / Q000378:metabolism* / Q000493:pharmacokinetics; D013006:Growth Hormone / Q000008:administration & dosage* / Q000378:metabolism; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage* / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate; D010289:Parenteral Nutrition, Total; D014176:Protein Biosynthesis; D011506:Proteins / Q000378:metabolism*; D011865:Radioisotope Dilution Technique
D011506:Proteins; D005973:Glutamine; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone